No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

Annette Juul Vangsted, Karen Søeby, Tobias W Klausen, Niels Abildgaard, Niels F Andersen, Peter Gimsing, Henrik Gregersen, Ulla Vogel, Thomas Werge, Henrik B Rasmussen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

20 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftB M C Cancer
Vol/bind10
Sider (fra-til)404
Antal sider8
ISSN1471-2407
DOI
StatusUdgivet - 1 jan. 2010
Udgivet eksterntJa

Fingeraftryk Dyk ned i forskningsemnerne om 'No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma'. Sammen danner de et unikt fingeraftryk.

Citationsformater